全文获取类型
收费全文 | 46324篇 |
免费 | 5133篇 |
国内免费 | 1396篇 |
专业分类
耳鼻咽喉 | 78篇 |
儿科学 | 2878篇 |
妇产科学 | 416篇 |
基础医学 | 4010篇 |
口腔科学 | 250篇 |
临床医学 | 3943篇 |
内科学 | 6663篇 |
皮肤病学 | 353篇 |
神经病学 | 1058篇 |
特种医学 | 842篇 |
外国民族医学 | 1篇 |
外科学 | 12422篇 |
综合类 | 7039篇 |
现状与发展 | 4篇 |
一般理论 | 1篇 |
预防医学 | 2561篇 |
眼科学 | 289篇 |
药学 | 3081篇 |
21篇 | |
中国医学 | 6195篇 |
肿瘤学 | 748篇 |
出版年
2024年 | 109篇 |
2023年 | 1089篇 |
2022年 | 1377篇 |
2021年 | 3024篇 |
2020年 | 2415篇 |
2019年 | 2248篇 |
2018年 | 2061篇 |
2017年 | 2191篇 |
2016年 | 2182篇 |
2015年 | 2064篇 |
2014年 | 3388篇 |
2013年 | 3401篇 |
2012年 | 2478篇 |
2011年 | 2727篇 |
2010年 | 2189篇 |
2009年 | 1986篇 |
2008年 | 1922篇 |
2007年 | 1837篇 |
2006年 | 1712篇 |
2005年 | 1437篇 |
2004年 | 1282篇 |
2003年 | 1106篇 |
2002年 | 912篇 |
2001年 | 870篇 |
2000年 | 661篇 |
1999年 | 569篇 |
1998年 | 535篇 |
1997年 | 432篇 |
1996年 | 379篇 |
1995年 | 417篇 |
1994年 | 366篇 |
1993年 | 321篇 |
1992年 | 308篇 |
1991年 | 318篇 |
1990年 | 255篇 |
1989年 | 259篇 |
1988年 | 223篇 |
1987年 | 199篇 |
1986年 | 183篇 |
1985年 | 216篇 |
1984年 | 186篇 |
1983年 | 113篇 |
1982年 | 161篇 |
1981年 | 141篇 |
1980年 | 102篇 |
1979年 | 123篇 |
1978年 | 78篇 |
1977年 | 72篇 |
1976年 | 75篇 |
1975年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 875 毫秒
101.
制作缺血性中风气虚血瘀证大鼠模型的实验研究 总被引:3,自引:0,他引:3
目的 探索建立缺血性中风气虚血瘀证大鼠模型的制作方法和评价体系。 相似文献
102.
缩泉丸对肾阳虚多尿大鼠内分泌及免疫功能的影响 总被引:4,自引:0,他引:4
目的 观察缩泉丸对肾阳虚多尿模型大鼠内分泌及免疫功能的影响.方法 用腺嘌呤250 mg/kg灌服大鼠4周,造成肾阳虚多尿模型,分别给予缩泉丸、肾气丸和去氨加压素(dDAVP)治疗4周,检测缩泉丸对体重、脏器系数、血清中皮质酮浓度和外周血T淋巴细胞亚群水平的影响.结果 模型组大鼠体重比正常对照组大鼠明显降低,dDAVP组、缩泉丸中、高剂量组与模型组大鼠体重相比,具有显著性差异(P<0.05或P<0.01).与正常对照组比较,模型组大鼠胸腺、肾上腺和垂体系数明显降低(P<0.05或P<0.01);与模型组比较,除缩泉丸低剂量组外,其余各治疗组的胸腺系数均明显提高,差异具有显著性(P<0.05);与模型组比较,垂体和肾上腺系数,仅在肾气丸组和缩泉丸高剂量组发现有明显提高,差异具有显著性(P<0.05).模型组具有较低的血清中皮质酮浓度,与正常对照组比较,具有非常显著性差异(P<0.01),肾气丸组和缩泉丸中、高剂量组血清中皮质酮浓度比模型组明显增加,具有显著性差异(P<0.05或P<0.01).与正常对照组比较,肾阳虚多尿模型组大鼠外周血T淋巴细胞CD3+百分比、CD3+/CD4+百分比明显减少,CD3+/CD8+百分比明显增加,差异具有显著性(P<0.05或P<0.01);与模型组比较,肾气丸组和缩泉丸低、中、高剂量组CD3+百分比、CD3+/CD4+百分比明显增加,CD3+/CD8+百分比明显减少,差异具有显著性,与模型组相比dDAVP组CD3+百分比、CD3+/CD4+百分比和CD3+/CD8+百分比均无显著性差异.结论 缩泉丸能够调节肾阳虚多尿大鼠的内分泌及免疫功能. 相似文献
103.
104.
R. A. Wolfe F. B. LaPorte A. M. Rodgers E. C. Roys G. Fant A. B. Leichtman 《American journal of transplantation》2007,7(S1):1404-1411
Turndowns of offers of deceased donor kidneys for transplantation can contribute to inefficiencies in the organ distribution system and inequality in access to donated organs. Match run data were obtained for 4967 'good' kidneys placed and transplanted in 2005 after fewer than 50 offers. These kidneys were not recovered from donation after cardiac death or expanded criteria donors, or from donors with a history of substance abuse. On average, these good kidneys were not accepted until after seven offers to candidates and after offers to 2.4 programs. Models for the likelihood of acceptance found several donor and candidate characteristics to be significantly related to acceptance rates (p < 0.05). After accounting for these variables, there remained 2- to 3-fold differences among transplant programs in acceptance rates. These models could be used to identify kidney transplant centers with exceptional acceptance practices. Several strategies might be employed to increase acceptance rates for good organs. 相似文献
105.
目的 研究丙泊酚对大鼠肢体缺血再灌注损伤后肾组织中肿瘤坏死因子-α(tumornecrosisfactor-α,TNF-α)、核因子-κB(nuclear factor-κxB,NF-κB)表达的影响。方法 24只SD雄性大鼠,随机分为假手术对照组(A组),肢体缺血再灌注组(B组)和丙泊酚干预组(C组),每组8只。采用免疫组织化学方法检测TNF-α、NF-κB的表达,行图像分析半定量。结果 B组大鼠肾组织中TNF-α、NF-κB的表达明显高于A组(P〈0.05),C组明显低于B组(P〈0.05)。结论 肢体缺血再灌注后有明显肾损伤,丙泊酚对肢体缺血再灌注肾损伤有一定程度的保护作用,其机制可能与下调大鼠肢体缺血再灌注损伤肾组织中TNF-α、NF-κB的过度表达有关。 相似文献
106.
E. Merieau A. Al Najjar J.-M. Halimi M. Sacquépée H. Nivet Y. Lebranchu M. Büchler 《American journal of transplantation》2007,7(11):2634-2636
A 40-year-old man who had been on hemodialysis for 25 months due to familial juvenile hyperuricemic nephropathy (FJHN) received a kidney transplant. Biopsy of his native kidney had shown tubulo-interstitial nephropathy. Genetic analysis confirmed abnormal uromodulin expression due to a mutation in the exon 4 of the UMOD gene. He had multiple tophi on the day of transplantation, including some on his fingers. He received immunosuppressive treatment including polyclonal antilymphocyte antibodies, mycophenolate mofetil, steroids and cyclosporine and achieved excellent renal function, with serum creatinine at 13 mg/L on day 10 posttransplantation and 9.4 mg/L at 6 months. His uric acid excretion rate increased from 4.4% at day 2 posttransplantation to 7.7% 6 months after transplantation. The number and sizes of the tophi were reduced 3 months posttransplantation, and nearly disappeared at month 6. Serum uric acid level decreased slowly from 650 mumol/L before transplantation to 300 mumol/L. Reduction of tophi was probably due to the absence of the mutated UMOD gene in the transplanted kidney. 相似文献
107.
J.D. Schold T.R. Srinivas G. Guerra A.I. Reed R.J. Johnson I.D. Weiner R. Oberbauer J.S. Harman A.W. Hemming H.U. Meier-Kriesche 《American journal of transplantation》2007,7(3):550-559
Research suggests that end-stage renal disease patients with elevated body mass index (BMI) have superior outcomes on dialysis. In contrast, low and high BMI patients represent the highest risk cohorts for kidney transplant recipients. The important question remains concerning how to manage transplant candidates given the potentially incommensurate impact of BMI by treatment modality. We conducted a retrospective analysis of waitlisted and transplanted patients in the United States from 1990 to 2003. We constructed Cox models to evaluate the effect of BMI on mortality of waitlisted candidates and identified risk factors for rapid weight change. We then assessed the impact of weight change during waitlisting on transplant outcomes. Decline in BMI on the waiting list was not protective for posttransplant mortality or graft loss across BMI strata. Substantial weight loss pretransplantation was associated with rapid gain posttransplantation. The highest risk for death was among listed patients with low BMI (13-20 kg/m(2), adjusted hazard ratio = 1.47, p < 0.01). Approximately one-third of candidates had a change in BMI category prior to transplantation. While observed declines in BMI may be volitional or markers of disease processes, there is no evidence that candidates have improved transplant outcomes attributable to weight loss. Prospective trials are needed to evaluate the efficacy of weight loss protocols for candidates of kidney transplantation. 相似文献
108.
Immunoadsorption in Severe C4d-Positive Acute Kidney Allograft Rejection: A Randomized Controlled Trial 总被引:2,自引:0,他引:2
G. A. Böhmig M. Wahrmann H. Regele M. Exner B. Robl K. Derfler T. Soliman P. Bauer M. Müllner W. Druml 《American journal of transplantation》2007,7(1):117-121
Antibody-mediated rejection (AMR) frequently causes refractory graft dysfunction. This randomized controlled trial was designed to evaluate whether immunoadsorption (IA) is effective in the treatment of severe C4d-positive AMR. Ten out of 756 kidney allograft recipients were included. Patients were randomly assigned to IA with protein A (N = 5) or no such treatment (N = 5) with the option of IA rescue after 3 weeks. Enrolled recipients were subjected to tacrolimus conversion and, if indicated, 'anti-cellular' treatment. All IA-treated patients responded to treatment. One death unrelated to IA occurred after successful reversal of rejection. Four control subjects remained dialysis-dependent. With the exception of one patient who developed graft necrosis, non-responders were subjected to rescue IA, however, without success. Because of a high graft loss rate in the control group the study was terminated after a first interim analysis. Even though limited by small patient numbers, this trial suggests efficiency of IA in reversing severe AMR. 相似文献
109.
110.
两种艾灸法对二肾一夹型高血压大鼠血压和血管内皮细胞内分泌功能的影响 总被引:4,自引:0,他引:4
目的:应用两种艾灸疗法治疗两肾一夹肾血管性高血压大鼠(2K1C-RHR),评价这两种艾灸疗法的降压作用,并对其降压机理作初步的探讨。方法:建立2K1C-RHR模型,并将其随机分为六组:灸法Ⅰ组(百会、神阙、足三里)、灸法Ⅱ组(关元、涌泉、足三里)、卡托普利组、灸法Ⅰ+卡托普利组、灸法Ⅱ+卡托普利组、高血压对照组,另设正常对照组。经过10天治疗后,测量血压,并测定血浆中内皮素(ET)、一氧化氮(NO)。结果:高血压对照组的收缩压(SBP)、舒张压(DBP)明显高于正常对照组,各治疗组的SBP、DBP明显低于高血压对照组(P<0.01),各治疗组间则没有明显差异(P>0.05)。血浆NO含量各组间没有明显差异(P>0.05)。各治疗组与正常对照组的血浆中ET含量明显低于高血压对照组(P<0.01)。各治疗组ET/NO比值接近正常对照组(P>0.05)且明显低于高血压对照组(P>0.05)。结论:两种艾灸疗法有良好的降压作用,其降压机理与及纠正ET与NO的失衡状态有关。 相似文献